Abstract:

Objective To retrospectively analyze the therapeutic effect of wide surgical excision combined with low-dose adjuvant interferon-alpha 2b on cutaneous malignant melanoma. Methods A total of 32 patients with cutaneous malignant melanoma received wide surgical excision after preoperative examination and staging. The excisions were performed with a margin measuring 1-2 cm from the visible lesions or biopsy scars. Surgical modalities included direct suture after excision （4 patients）, dactylolysis or toe amputation （6 patients）, free skin grafting （15 patients）, random skin flap transfer （3 patients） and pedicle skin flap transfer （4 patients）. Lymph nodes were selectively dissected in 9 patients with regional transfer of lymph nodes, and inguinal lymph nodes were cleared away in 2 patients. One week after the operation, patients received adjuvant therapy with subcutaneous injection of interferon-alpha 2b （3 million IU, thrice per week） for one to three years. Results Preoperative tumor staging revealed 21 cases of cutaneous malignant melanoma at stage Ⅱ, and 11 cases at stage Ⅲ. The excisions healed by the first stage in all the patients. Up to June 2011, 2 patients had been lost to follow up, 5 patients with stage Ⅲ melanoma had died. Survival was observed in all of the 4 patients receiving 1-year follow up, 12 of 13 patients receiving 1-3 year follow up, 5 of 7 patients receiving 3-5 year follow up, and 4 of 6 receiving 5-year follow up. Of the 25 surviving patients, regional lymph node metastasis was observed in 8 patients, which developed within 2 years after the operation in 2 patients. The adjuvant therapy with interferon-alpha 2b lasted 3 years in 8 patients, and more than 1 year in 11 patients. Side effects were mild. Conclusion Wide surgical excision plus low-dose interferon-alpha 2b is effective for the treatment of stage Ⅱ and Ⅲ cutaneous malignant melanoma with lower local recurrence and higher survival rate.

Key words: therapy